Annual Accounts Payable
$2.79 M
-$1.67 M-37.46%
December 31, 2023
Summary
- As of February 7, 2025, TNGX annual accounts payable is $2.79 million, with the most recent change of -$1.67 million (-37.46%) on December 31, 2023.
- During the last 3 years, TNGX annual accounts payable has risen by +$944.00 thousand (+51.28%).
- TNGX annual accounts payable is now -37.46% below its all-time high of $4.45 million, reached on December 31, 2022.
Performance
TNGX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.11 M
+$3.05 M+287.19%
September 30, 2024
Summary
- As of February 7, 2025, TNGX quarterly accounts payable is $4.11 million, with the most recent change of +$3.05 million (+287.19%) on September 30, 2024.
- Over the past year, TNGX quarterly accounts payable has increased by +$1.33 million (+47.65%).
- TNGX quarterly accounts payable is now -34.87% below its all-time high of $6.31 million, reached on September 30, 2022.
Performance
TNGX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TNGX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.5% | +47.6% |
| 3 y3 years | +51.3% | -34.7% |
| 5 y5 years | +51.3% | -34.7% |
TNGX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -37.5% | at low | -34.9% | +287.2% |
| 5 y | 5-year | -37.5% | +51.3% | -34.9% | +287.2% |
| alltime | all time | -37.5% | +51.3% | -34.9% | +287.2% |
Tango Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.11 M(+287.2%) |
| Jun 2024 | - | $1.06 M(-72.8%) |
| Mar 2024 | - | $3.90 M(+40.0%) |
| Dec 2023 | $2.79 M(-37.5%) | $2.79 M(-1.8%) |
| Sep 2023 | - | $2.84 M(-40.8%) |
| Jun 2023 | - | $4.79 M(-23.9%) |
| Mar 2023 | - | $6.30 M(+41.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $4.45 M(+38.0%) | $4.45 M(-29.5%) |
| Sep 2022 | - | $6.31 M(+272.9%) |
| Jun 2022 | - | $1.69 M(-49.7%) |
| Mar 2022 | - | $3.37 M(+4.4%) |
| Dec 2021 | $3.23 M(+75.2%) | $3.23 M(+3.8%) |
| Sep 2021 | - | $3.11 M(+68.9%) |
| Dec 2020 | $1.84 M | $1.84 M |
FAQ
- What is Tango Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Tango Therapeutics?
- What is Tango Therapeutics annual accounts payable year-on-year change?
- What is Tango Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Tango Therapeutics?
- What is Tango Therapeutics quarterly accounts payable year-on-year change?
What is Tango Therapeutics annual accounts payable?
The current annual accounts payable of TNGX is $2.79 M
What is the all time high annual accounts payable for Tango Therapeutics?
Tango Therapeutics all-time high annual accounts payable is $4.45 M
What is Tango Therapeutics annual accounts payable year-on-year change?
Over the past year, TNGX annual accounts payable has changed by -$1.67 M (-37.46%)
What is Tango Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TNGX is $4.11 M
What is the all time high quarterly accounts payable for Tango Therapeutics?
Tango Therapeutics all-time high quarterly accounts payable is $6.31 M
What is Tango Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TNGX quarterly accounts payable has changed by +$1.33 M (+47.65%)